Donor-matched GA1CAR T/HER2 FabLRT and scFv CAR T cells showed similar efficacy in controlling HCC1954 tumor growth, whereas tumors in mice treated only with GA1CAR T cells or FabLRT grew progressively (fig. Here, ERBB2 is linked to neoplasm.